Ads
related to: Novavax
Search results
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 1 hour agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Company News For May 13, 2024
Zacks via Yahoo Finance· 3 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 17 hours agoNovavax , Inc. (NASDAQ:NVAX) has entered into a multibillion-dollar global co-development and...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 9 hours agoPositive Points Novavax Inc (NASDAQ:NVAX) announced a significant global co-development and co-commercialization agreement with Sanofi, expected to generate approximately ...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 5 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 15 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 1 day agoNovavax (NASDAQ:NVAX) First Quarter 2024 Results Key Financial Results Revenue: US$93.9m (up 16%...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 3 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
